BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ishibashi Y, Kobayashi H, Ando T, Okajima K, Oki T, Tsuda Y, Shinoda Y, Sawada R, Tanaka S. Prognostic factors in patients with bone metastasis of lung cancer after immune checkpoint inhibitors: A retrospective study. World J Orthop 2024; 15(12): 1155-1163 [PMID: 39744733 DOI: 10.5312/wjo.v15.i12.1155]
URL: https://www.wjgnet.com/2218-5836/full/v15/i12/1155.htm
Number Citing Articles
1
Min Dong, Guili Zheng, Fangyuan Yu, Jiaqi Yin, Chen Zhong. Immune checkpoint inhibition in bone metastases: lesion response heterogeneity, the osteoimmune niche, and microenvironment-directed therapy. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1959101